Pharmacology and Toxicology
Showing page 18 of 22 pages of list content
-
Human ACE2 peptide mimics block SARS-CoV-2 Pulmonary Cells Infection
This article's authors -
A repurposed drug screen identifies compounds that inhibit the binding of the COVID-19 spike protein to ACE2
This article's authors -
Triphosphates of the Two Components in DESCOVY and TRUVADA are Inhibitors of the SARS-CoV-2 Polymerase
This article's authors -
Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and FlipGFP-based reporter assay
This article's authors -
Identification of SARS-CoV-2 induced pathways reveal drug repurposing strategies
This article's authors -
Tafenoquine inhibits replication of SARS-Cov-2 at pharmacologically relevant concentrations in vitro
This article's authors -
In vitroscreening of herbal medicinal products for their supportive curing potential in the context of SARS-CoV-2
This article's authors -
Pharmacokinetics of Orally Administered GS-441524 in Dogs
This article's authors -
Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein’s Receptor Binding Domain and Recombinant Human ACE2
This article's authors -
Bromodomain and extraterminal protein inhibitor, apabetalone (RVX-208), reduces ACE2 expression and attenuates SARS-CoV-2 infection in vitro
This article's authors